rhBMP-2 using biphasic calcium phosphate block as a carrier induces new bone formation in a rat subcutaneous tissue |
Kim, Joon-Il
(Department of Periodontology, Research Institute for Periodontal Regeneration, College of Dentistry, Yonsei University)
Yun, Jeong-Ho (Department of Dentistry, College of Medicine, Kwandong University, Myongji Hospital) Chae, Gyung-Joon (Department of Periodontology, Research Institute for Periodontal Regeneration, College of Dentistry, Yonsei University) Jung, Sung-Won (Department of Periodontology, Research Institute for Periodontal Regeneration, College of Dentistry, Yonsei University) Kim, Chang-Sung (Department of Periodontology, Research Institute for Periodontal Regeneration, College of Dentistry, Yonsei University) Cho, Kyoo-Sung (Department of Periodontology, Research Institute for Periodontal Regeneration, College of Dentistry, Yonsei University) |
1 | Urist MR. Bone: Formation by autoinduction. Science 1965;150:893-899. DOI PUBMED ScienceOn |
2 | Sampath TK, Maliakal JC, Hauschka PV. Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J Biol Chem 1992;267:20352-20362. PUBMED |
3 | Jung UW, Choi SY, Pang EK, et al. The Effect of varying the particle size of beta tricalcium phosphate carrier of recombinant human bone morphogenetic protein-4 on bone formation in rat calvarial defects. J Periodontol 2006;77: 765-772. DOI ScienceOn |
4 | Kim CS, Choi SH, Choi BK, et al. The effect of recombinant human bone morphogenetic protein-4 on the osteoblastic differentiation of mouse calvarial cells affected by Porphyromonas gingivalis. J Periodontol 2002;73:1126-1132. DOI ScienceOn |
5 | Kim CS, Kim JI, Kim J, et al. Ectopic bone formation associated with recombinant human bone morphogenetic protein-2 using absorbable collagen sponge and beta tricalcium phosphate as carriers. Biomaterials 2005;26:2501-2507. DOI ScienceOn |
6 | Kawamura M, Urist MR. Human fibrin is a physiologic delivery system for bone morphogenetic protein. Clin Orthop Relat Res 1988;235:302-310. PUBMED |
7 | Hong SJ, Kim CS, Han DK, et al. The effect of a fibrin-fibronectin/ß-tricalcium phosphate/recombinant human bone morphogenetic protein-2 system on bone formation in rat calvarial defects. Biomaterials 2006;27:3810-3816. DOI ScienceOn |
8 | Miki T, Imai Y. Osteoinductive potential of freeze-derived, biodegredable, poly(glycolic acid-co-lactic acid) disks incorporated with bone morphogenetic protein in skull defects of rats. Int J Oral Maxillofac Surg 1996;25:402-426. DOI ScienceOn |
9 | Cornell CN, Lane JM. Current understanding of osteoconduction in bone regeneration. Clin Orthop Relat Res 1998;355 Suppl:S267-273. PUBMED |
10 | Yuan H, van Blitterswijk CA, de Groot K, de Bruijn JD. A comparison of bone formation in biphasic calcium phosphate (BCP) and hydroxyapatite (HA) implanted in muscle and bone of dogs at different time periods. J Biomed Mater Res A 2006;78:139-147. PUBMED |
11 | Boden SD, Kang J, Sandhu H, Heller JG. Use of recombinant human bone morphogentic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies. Spine 2002;27:2662-2273. DOI ScienceOn |
12 | Yang Z, Yuan H, Tong W, et al. Osteogenesis in extraskeletally implanted porous calcium phosphate ceramics: variability among different kinds of animals. Biomaterials 1996;17:2131-2137. DOI PUBMED ScienceOn |
13 | Ahn SH, Kim CS, Suk HJ, et al. Effect of recombinant human bone morphogenetic protein- 4 with carriers in rat calvarial defects. J Periodontol 2003;74:787-797. DOI ScienceOn |
14 | Choi SH, Kim CK, Cho KS, et al. Effect of recombinant human bone morphogenetic protein-2/absorbable collagen sponge (rhBMP-2/ACS) on healing in 3-wall intrabony defects in dogs. J Periodontol 2002;73:63-72. DOI ScienceOn |
15 | Gauthier O, Bouler JM, Aguado E, Pilet P, Daculsi G. Macroporous biphasic calcium phosphate ceramics: influence of macropore diameter and macroporosity percentage on bone ingrowth. Biomaterials 1998;19:133-139. DOI ScienceOn |
16 | Yasko AW, Lane JM, Fellinger EJ, et al. The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). A radiographic, histological, and biomechanical study in rats. J Bone Joint Surg Am 1992;74:659-670. DOI PUBMED |
17 | Hyun SJ, Choi SH, Chai JK, et al. Effect of recombinant human bone morphogenetic protein-2, -4 and -7 on bone formation in rat calvarial defects. J Periodontol 2005;76: 1667-1674. DOI ScienceOn |
18 | Le Guehennec L, Goyenvalle E, Aguado E, et al. Small-animal models for testing macroporous ceramic bone substitutes. J Biomed Mater Res B Appl Biomater 2005;72: 69-78. PUBMED |
19 | Schopper C, Ziya-Ghazvini F, Goriwoda W, et al. HA/TCP compounding of a porous CaP biomaterial improves bone formation and scaffold degradation--a long-term histological study. J Biomed Mater Res B Appl Biomater 2005;74:458-467. PUBMED |
20 | Oda S, Kinoshita A, Higuchi T, Shizuya T, Ishikawa I. Ectopic bone formation by biphasic calcium phosphate(BCP) combined with recombinant human bone morphogenetic protein-2 (rhBMP-2). J Med Dent Sci 1997;44: 53-62. PUBMED |
21 | Habibovic P, Yuan H, van den Doel M, et al. Relevance of osteoinductive biomaterials in critical-sized orthotopic defect. J Orthop Res 2006;24:867-876. DOI ScienceOn |
22 | Daculsi G, Layrolle P. Osteoinductive properties of micro macroporous biphasic calcium phosphate bioceramics. Key Eng Mater 2004;254-256:1005-1008. DOI |
23 | Daculsi G, Laboux O, Malard O, Weiss P. Current state of the art of biphasic calcium phosphate bioceramics. J Mater Sci Mater Med 2003;14:195-200. DOI ScienceOn |
24 | Le Nihouannen D, Daculsi G, Saffarzadeh A, et al. Ectopic bone formation by microporous calcium phosphate ceramic particles in sheep muscles. Bone 2005;36:1086-1093. DOI ScienceOn |
25 | Yoshida K, Bessho K, Fujimura K, et al. Osteoinduction capability of recombinant human bone morphogenetic protein-2 in intramuscular and subcutaneous sites: an experimental study. J Craniomaxillofac Surg 1998;26:112-115. DOI PUBMED ScienceOn |
26 | Pang EK, Im SU, Kim CS, et al. Effect of recombinant human bone morphogenetic protein-4 dose on bone formation in rat calvarial defect model. J Periodontol 2004;75:1364-1370. DOI ScienceOn |
27 | Lindholm TS, Gao TJ. Functional carriers for bone morphogenetic proteins. Ann Chir Gynaecol Suppl 1993;207:3-12. PUBMED |
28 | Gao TJ, Kousinioris NA, Wozney JM, Winn S, Uludag H. Synthetic thermoreversible polymers are compatible with osteoinductive activity of recombinant human bone morphogenetic protein 2. Tissue Eng 2002;8:429-440. DOI ScienceOn |
29 | LeGeros RZ, Lin S, Rohanizadeh R, Mijares D, LeGeros JP. Biphasic calcium phosphate bioceramics: preparation, properties and applications. J Master Sci Mater Med 2003;14:201-209. DOI ScienceOn |
30 | Nery EB, LeGeros RZ, Lynch KL, Lee K. Tissue response to biphasic calcium phosphate ceramic with different ratios of HA/beta TCP in periodontal osseous defects. J Periodontol 1992 ;63:729-735. DOI PUBMED |
31 | Han DK, Kim CS, Jung UW, et al. Effect of a fibrin-fibronectin sealing system as a carrier for recombinant human bone morphogenetic protein-4 on bone formation in rat calvarial defects. J Periodontol 2005;76:2216-2222. DOI ScienceOn |
32 | Manjubala I, Sastry TP, Kumar RV. Bone in-growth induced by biphasic calcium phosphate ceramic in femoral defect of dogs. J Biomater Appl 2005;19:341-360. DOI ScienceOn |
33 | Okubo Y, Bessho K, Fujimura K, et al. Comparative study of intramuscular and intraskeletal osteogenesis by recombinant human bone morphogenetic protein-2. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;87:34-8. DOI ScienceOn |
34 | Aldinger G, Herr G, Kusswetter W, et al. Bone morphogenetic protein: a review. Int Orthop 1991;15:169-177. PUBMED |